This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: GNC JCP MAR TRIP WFM

NEW YORK (TheStreet) -- RATINGS CHANGES

Abbvie (ABBV) was upgraded to overweight from equal-weight. Twelve-month price target is $60. Company has an attractive pipeline and can generate healthy growth over the coming quarters, Morgan Stanley said.

Fortress Investment (FIG) was downgraded to hold at TheStreet Ratings.

FirstEnergy (FE) was upgraded at Jefferies to buy from hold. Valuation call with 12-month price target of $37, Jefferies said.

GNC (GNC) was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $40. Company has a lackluster outlook for the remainder of the year, Deutsche Bank said.

Hilton (HLT) was upgraded at Morgan Stanley to overweight. Twelve-month price target is $27. Company has strong fundamentals and there is upside for Waldorf Astoria valuation, Morgan Stanley said.

Hilton was upgraded at MKM Partners to buy from neutral. Twelve-month price target is $27. Stock has underperformed, but has near-term catalysts, MKM Partners said.

Infinity Pharmaceutical (INFI) was upgraded at Jefferies to buy from hold. Commerical competitiveness already priced in and risk/reward is attractive, Jefferies said. Twelve-month price target is $13. Buy rating.

J.C. Penney (JCP - Get Report) was upgraded at UBS to neutral from sell. Less downside in SSS/GM risk for near term, UBS said. Twelve-month price target is $9.

Intelligent Systems (INS) was downgraded to hold at TheStreet Ratings.

Marriott (MAR) was downgraded at Morgan Stanley to equal-weight. Twelve-month price target is $64. Valuation call, as the stock has outperformed its peers by 14% year to date, Morgan Stanley said.

Merck (MRK) was downgraded at Morgan Stanley to equal-weight from overweight. Twelve-month price target is $60. Stock has outperformed and risk reward now balanced, Morgan Stanley said.

Fresh Market (TFM) was downgraded at Sterne Agee to underperform. Twelve-month price target is $29. Industry competition is heating up, Sterne Agee said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
JCP $7.85 -7.65%
TRIP $91.21 2.20%
AAPL $129.09 0.49%
FB $79.75 0.99%
GOOG $571.34 2.32%

Markets

DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs